Belatacept and sirolimus prolong nonhuman primate islet allograft survival: adverse consequences of concomitant alefacept therapy
about
Tolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal BlockageTransplantation tolerance and its outcome during infections and inflammationAlefacept promotes immunosuppression-free renal allograft survival in nonhuman primates via depletion of recipient memory T cells.Initial in vivo experience of pig artery patch transplantation in baboons using mutant MHC (CIITA-DN) pigsIn vitro testing of an anti-CD40 monoclonal antibody, clone 2C10, in primates and pigs.Tacrolimus to Belatacept Conversion Following Hand Transplantation: A Case ReportStudies Introducing Costimulation Blockade for Vascularized Composite Allografts in Nonhuman Primates.Primate models in organ transplantationBiologic agents in islet transplantation.Transplantation of xenogeneic islets: are we there yet?Targeting co-stimulatory pathways: transplantation and autoimmunity.Recollective homeostasis and the immune consequences of peritransplant depletional induction therapy.Islet cell xenotransplantation: a serious look toward the clinicClinical consequences of circulating CD28-negative T cells for solid organ transplantation.Memory T cells in organ transplantation: progress and challenges.T Cell Cosignaling Molecules in Transplantation.Impact of Immune-Modulatory Drugs on Regulatory T Cell.Selective Targeting of High-Affinity LFA-1 Does Not Augment Costimulation Blockade in a Nonhuman Primate Renal Transplantation Model.Rhesus monkeys for a nonhuman primate model of cytomegalovirus infections.The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus Macaques.CD8+ Effector T Cell Migration to Pancreatic Islet Grafts Is Dependent on Cognate Antigen Presentation by Donor Graft CellsBelatacept: the challenges with transformational drugs.Transplantation: The promise of co-stimulatory blockade in transplantation.The Role of Costimulation Blockade in Solid Organ and Islet Xenotransplantation.Retrospective evaluation of the efficacy and safety of belatacept with thymoglobulin induction and maintenance everolimus: A single-center clinical experience.Simultaneous Recognition of Allogeneic MHC and Cognate Autoantigen by Autoreactive T Cells in Transplant Rejection.T Cell Repertoire Maturation Induced by Persistent and Latent Viral Infection Is Insufficient to Induce Costimulation Blockade Resistant Organ Allograft Rejection in Mice.
P2860
Q26778646-C835653F-5EB4-432D-B8A2-D0565E8F044CQ26829817-40892643-9BA4-4413-9F4A-E1991948F592Q33881015-8D3E6BD2-64BC-4345-BDF4-00919794FFC7Q35202459-8E93AD15-B802-457F-BB1F-08A152754385Q36289120-086219B6-9084-408A-B81B-D6A9047CC456Q36813200-7860C3F4-D06D-4659-94F0-92A3B6E30669Q37031340-3842CB69-CD38-4C30-AE39-F020DD9103AEQ37122367-5BC1E4EA-F7BF-4E99-88F6-86F8F21A8D7EQ38126884-D98543C4-853D-44EE-A80C-51DB0293F1D6Q38127152-136AF32A-8206-4A41-B466-F8CE7B702203Q38150101-A498F12F-8647-47A9-9C7B-657BB66A33D8Q38187176-70504B4B-00CA-4267-8969-95138D6411ABQ38210098-BCAA3D8E-3D3B-4CFE-AAEE-2BEA64D94813Q38568848-BDA3D3C6-0DB7-4A93-8694-E20D665825B5Q38753494-032BA45A-1FF7-474D-811E-35B527E6936BQ38837473-0632F79D-BA55-4DF3-9390-A6087C5EC302Q38918124-2AFD8AF3-1777-4C58-AAD9-A52A9221DB79Q39152748-759C89AA-BF05-4D48-BB73-1ECDAF654278Q40059344-E51E838F-523E-485F-8C52-D492740461E5Q40584637-8546A7FF-D9C8-4CB7-BC70-BA32B56FCB4AQ41091257-7C938055-48AB-4A78-952A-39AE96A211A5Q42120388-6BE8A04F-2C5A-4FCB-8705-02B9EF31A999Q44146444-40BCD049-BAA3-4D13-83F0-212A1F6C4CF0Q44770974-00215061-396D-4885-867B-5A8DA87EC120Q45964615-1832DBF8-CC41-48C5-8309-E0B5CCA9F612Q48293644-7F0AB704-4241-458B-B5DA-57205FE97E0CQ55436826-9BE67669-7B52-45BC-B572-19F841C96CCD
P2860
Belatacept and sirolimus prolong nonhuman primate islet allograft survival: adverse consequences of concomitant alefacept therapy
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Belatacept and sirolimus prolo ...... concomitant alefacept therapy
@ast
Belatacept and sirolimus prolo ...... concomitant alefacept therapy
@en
type
label
Belatacept and sirolimus prolo ...... concomitant alefacept therapy
@ast
Belatacept and sirolimus prolo ...... concomitant alefacept therapy
@en
prefLabel
Belatacept and sirolimus prolo ...... concomitant alefacept therapy
@ast
Belatacept and sirolimus prolo ...... concomitant alefacept therapy
@en
P2093
P2860
P1476
Belatacept and sirolimus prolo ...... concomitant alefacept therapy
@en
P2093
A P Turner
C P Larsen
E A Strobert
F V Leopardi
I R Badell
P W Thompson
P2860
P304
P356
10.1111/J.1600-6143.2012.04341.X
P407
P577
2012-12-27T00:00:00Z